Abstract:Abstract It is unclear how pathological aging of the inflammatory system relates to Alzheimer’s disease (AD). We tested whether age-related inflammatory changes in cerebrospinal fluid (CSF) and plasma exist across different stages of AD, and whether such changes related to AD pathology. Linear regression was first used model chronological age in amyloid-β negative, cognitively unimpaired individuals (Aβ− CU; n = 312) based on a collection of 73 inflammatory proteins measured in both CSF and plasma. Fitted models were then applied on protein levels from Aβ+ individuals with mild cognitive impairment (Aβ+ MCI; n = 150) or Alzheimer’s disease dementia (Aβ+ AD; n = 139) to test whether the age predicted from proteins alone (“inflammatory age”) differed significantly from true chronological age. Aβ− individuals with subjective cognitive decline (Aβ− SCD; n = 125) or MCI (Aβ− MCI; n = 104) were used as an independent contrast group. The difference between inflammatory age and chronological age ( InflammAGE score) was then assessed in relation to core AD biomarkers of amyloid, tau, and cognition. Both CSF and plasma inflammatory proteins were significantly associated with age in Aβ− CU individuals, with CSF-based proteins predicting chronological age better than plasma-based counterparts. Meanwhile, the Aβ− SCD and validation Aβ− CU groups were not characterized by significant inflammatory aging, while there was increased inflammatory aging in Aβ− MCI patients for CSF but not plasma inflammatory markers. Both CSF and plasma inflammatory changes were seen in the Aβ+ MCI and Aβ+ AD groups, with varying degrees of change compared to Aβ− CU and Aβ− SCD groups. Finally, CSF inflammatory changes were highly correlated with amyloid, tau, general neurodegeneration, and cognition, while plasma changes were mostly associated with amyloid and cognition. Inflammatory pathways change during aging and are specifically altered in AD, tracking closely with pathological hallmarks. These results have implications for tracking AD progression and for suggesting possible pathways for drug targeting.

IgM response against amyloid-beta in aging: a potential peripheral protective mechanism

Altered T cell reactivity to β-amyloid-related antigens in early Alzheimer's disease

Characterization of peripheral immune cell populations in stable and progressive Alzheimer’s disease

T Cell Responses to Neural Autoantigens Are Similar in Alzheimer's Disease Patients and Age-Matched Healthy Controls

T Cell Responses to Neural Autoantigens Are Similar in Alzheimer’s Disease Patients and Age-Matched Healthy Controls

The adaptive immune system restrains Alzheimer’s disease pathogenesis by modulating microglial function

Alterations in Immune Functions During Normal Aging and Alzheimer's Disease

Alterations in immune functions during normal aging and Alzheimer's disease.

Changes of Aβ Antibody and Cytokines in Peripheral Blood from Patients with Alzheimer's Disease

Dissecting the immune response of CD4 + T cells in Alzheimer's disease

CSF biomarkers of immune activation and Alzheimer's disease for predicting cognitive impairment risk in the elderly

Single-cell multiomic analysis reveals the involvement of Type I interferon-responsive CD8+ T cells in amyloid beta-associated memory loss

Proteome-wide analysis identifies plasma immune regulators of amyloid-beta progression

Amyloid-β aggregates activate peripheral monocytes in mild cognitive impairment

Accelerated inflammatory aging in Alzheimer’s disease and its relation to amyloid, tau, and cognition

Hyperactivation of monocytes and macrophages in MCI patients contributes to the progression of Alzheimer's disease

The association of microbial infection and adaptive immune cell activation in Alzheimer's disease

β-Amyloids and Immune Responses Associated with Alzheimer's Disease

Altered memory B-cell homeostasis in human aging.

Peripheral Immune Cells Contribute to the Pathogenesis of Alzheimer's Disease

Age-Dependent and Aβ-Induced Dynamic Changes in the Subcellular Localization of HMGB1 in Neurons and Microglia in the Brains of an Animal Model of Alzheimer's Disease